Bayesian Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,029	Closed	-$267K	–	928
2024 Q1	$267K	Buy	+4,029	New	+$267K	0.03%	588